| Prev Close | 5.92 |
| Open | 5.89 |
| Day Low/High | 5.68 / 6.21 |
| 52 Wk Low/High | 4.82 / 26.96 |
| Volume | 5.60M |
Canopy Growth Corporation (CGC)
5.73
0.19
3.21
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 393.71B |
| Market Cap | 2.11B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Keeping an Eye on 2 Cannabis Stocks Until Market Conditions Improve
I'm looking at a possible inverse head and shoulders forming on many cannabis charts.
Booyah, MJ!
beat (and share price +6%) should really help our recent buy as Canopy Growth represents 7.4% of the ETF: $CGC 3Q NET REV. C$141M; EST. C$138M$CGC 3Q ADJ EBITDA (C$67M); EST. (C$65M) initial stock reaction: +10% ¿¿ #cannabis ¿https://t.co/LgDhJDB0sn...
Canadian Cannabis Stocks
After being weak recently, Canadian cannabis stocks ( and ) are up by nearly +10% today. In serving the Canadian pot market, these companies are disadvantaged vs. the U.S. multi state operators (held in ). I expect some quick "ketchup" by the MSOS c...
7 Ways to Invest in the Future of Cannabis
Leading advisors pick four favorite cannabis purveyors, two marijuana ETFs and one ancillary tobacco segment firm.
Cannabis Stocks Are Lighting Up Investors' Portfolios
ETF MSOS is seen as an opportunity to get exposure to stocks that are not yet U.S. listed.
I'm Looking at My Go-To Cannabis Play Village Farms
I'm willing to take a small shot on a September call spread and ride through earnings.
Subscriber Comment of the Day (Part Trois) and My Response
nikogeorge dougie kass • 15 minutes ago I see investments in MSOs (multi-state operators) (i.e. , , , ) as the ones that benefit while the wait for legislation grinds into existence. As they are the ones that have the state licenses, which are limit...
Analysts Are High on Buying Gage Cannabis
Viridian Capital believes Michigan could be the third biggest state for cannabis sales behind California and Colorado.
Jim Cramer: With Reopening Spirits High, I'm Looking at Constellation Brands
A bit of good news from Pernod Ricard came across my screen, so let's see if we can have a toast to other, similar liquor brands.
Light Up Your Portfolio With These 15 Cannabis Stocks and ETFs
Leading advisors offer their favorite ideas for investors looking for exposure to the growing marijuana market.
Covid Recovery, Inflation, Jobs Data, AMD, Crypto Regulation?, Too Many Teslas
Seasonally adjusted data, always suspect, has never meant less than now, when there really is no historical comparison -- to anything
Constellation Brands' Downside Price Gap Has Me on the Sidelines
A look at STZ after its latest earnings report.
Here's What Investors Need to Wait for With Constellation Brands
This stock can be bought for a trade today, but only by someone who watches their positions closely and acts aggressively.
Jim Cramer: Go Ahead, Try and Bet Against Me
You can listen to the haters on Twitter and Reddit, or you can see what I've been doing since 1979: trying to help the average Joe make some money.
Stifel Expecting Pressure On Canadian Cannabis Companies
More competition at lower prices will make it harder to be profitable.
Canopy Growth Has Corrected but Needs More Accumulation
Let's review the charts and indicators.
The 1999/2000 Bubble Didn't End All at Once...and This One Might Not Either
One possible outcome: The party ends relatively soon for some of the more speculative names, while other high-multiple stocks remain strong until inflation and the Fed become issues.
Jim Cramer: The Power of Memory to Make Money
Remember this: the market's often wrong.
Cronos Group Is Showing Us a Bullish Picture
Traders should look to buy available weakness into the $12-$11 area.
Canopy Growth Is Hot, and Here's How I'm Trading It
They really do not have very high hopes for the short to medium term future. Yet, the market buys their news.
Amazing Small-Caps, Minimum Wage, An Unhealthy Survey, Trading Nvidia, Chegg
The Russell 2000 has now soared 16% year to date, nearly twice the Nasdaq Composite's 8.5% move.
It's All (Cisco) Systems Go
CSCO is edging toward a major breakout level. Let's check the charts.
Things Are Heating Up for Canopy Growth: Our New Price Targets
Shares of the cannabis stock have recently strengthened.
Cannabis Leader Canopy Growth Can Climb Higher
Here's how to play CGC.
As the Focus on Psychedelic Stocks Increases, So Do the Valuations
The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine, Cybin, and Mydecine Innovations.
Democrat Wins Means Cannabis Wins
Georgia's election results have given the industry a big green light, meaning positive moves are expected out of cannabis stocks.
Constellation Brands Makes a Major Upside Breakout
Let's take a fresh look at the charts and indicators.
